Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy-Reference-Cited by-同舟云学术

Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy

Published:2024-01 Issue:1 Volume:10 Page:e23563
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Zhao Feng,Yang Hui,Gao Zehong,Liu Huamei,Wu Pingling,Li Binbin,Yu Heming,Shao Jiahui^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference37 articles.

1. Cu(II) potentiation of Alzheimer Abeta1-40 cytotoxicity and transition on its secondary structure;Dai;Acta Biochim. Biophys. Sin.,2006

2. Abeta aggregation and possible implications in Alzheimer's disease pathogenesis;Bharadwaj;J. Cell Mol. Med.,2009

3. Amyloid-beta aggregation;Finder;Neurodegener. Dis.,2007

4. The canonical pattern of Alzheimer's disease atrophy is linked to white matter hyperintensities in normal controls, differently in normal controls compared to in AD;Riphagen;Neurobiol. Aging,2022

5. Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease;Paliwal;Neurobiol. Aging,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on recent progress in chitosan composite gels for biomedical uses;International Journal of Biological Macromolecules;2024-06

2. Ni^II-containing l-glutamic acid cross-linked chitosan anchored on Fe₃O₄/f-MWCNT: a sustainable catalyst for the green reduction and one-pot two-step reductive Schotten–Baumann-type acetylation of nitroarenes;Nanoscale Advances;2024